NCT05251714 CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05250336 Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer Status UNKNOWN Phase N/A
NCT05247463 English Mammography Screening Outcomes by Age, Frequency and Test Threshold Status ENROLLING_BY_INVITATION Phase N/A
NCT05245812 Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy Status RECRUITING Phase NA
NCT05243641 Neratinib and Capmatinib Combination (Phase Ib/II) in Metastatic Breast Cancer and Inflammatory Breast Cancer Patients With Abnormal HER-family and c-Met Pathway Activity as Measured by the CELsignia Signaling Analysis Test Status TERMINATED Phase PHASE1/PHASE2
NCT05241405 Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological Cancer Status RECRUITING Phase NA
NCT05241119 Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant Chemotherapy Status RECRUITING Phase NA
NCT05239663 GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer Status TERMINATED Phase PHASE3
NCT05239143 P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05236387 Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection Status TERMINATED Phase N/A
NCT05234996 The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study Status COMPLETED Phase NA
NCT05232916 Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects Status RECRUITING Phase PHASE3
NCT05232084 Different Volumes of Erector Spinae Plane Block for Breast Surgery Status COMPLETED Phase NA
NCT05231863 Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study Status UNKNOWN Phase N/A
NCT05228951 Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC Status RECRUITING Phase PHASE2
NCT05226871 Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies Status ACTIVE_NOT_RECRUITING Phase PHASE2